This inventor holds 2 USPTO granted patents. Top assignee: Santen Pharmaceutical Co., Ltd.. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Nobuaki Miyawaki: Innovator in Pharmaceutical Chemistry
Introduction
Nobuaki Miyawaki is a notable inventor based in Sanda, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on urea derivatives. With a total of 2 patents, his research has the potential to impact various therapeutic applications.
Latest Patents
Miyawaki's latest patents include the development of 1,3-dialkylurea derivatives. These compounds are particularly noteworthy for their hydroxyl group modifications, which may enhance their efficacy in pharmaceutical formulations. His work in this area demonstrates a commitment to advancing drug development and improving patient outcomes.
Career Highlights
Miyawaki is currently employed at Santen Pharmaceutical Co., Ltd., where he continues to explore new avenues in drug discovery and development. His expertise in chemical synthesis and formulation has positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Throughout his career, Miyawaki has collaborated with esteemed colleagues such as Yoichi Kawashima and Ken-ichi Fujimura. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Nobuaki Miyawaki's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His ongoing work promises to lead to advancements that could benefit many in the healthcare sector.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile